Related Experiment Video
Updated: Jan 8, 2026

07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.3K
Technology and Dementia Preconference
Emma Dixon1, Elizabeth Gilman1, Kandianos Emmanouil Sakalidis2
1Clemson University, Clemson, SC, USA.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 23, 2025
Summary
Individuals with Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), or early dementia are exploring AI tools for workplace support. However, current tools lack adjustability, sometimes causing self-consciousness and tool abandonment.
Area of Science:
- Cognitive Science
- Human-Computer Interaction
- Occupational Health
Background:
- Individuals with Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), or early-onset dementia risk job loss.
- Workplace accommodations are crucial but can be challenging.
- Digital accommodations offer potential support for this population.
Purpose of the Study:
- To understand the experiences of individuals with SCD, MCI, or early-onset dementia in the workplace.
- To identify tools utilized by these individuals to maintain employment.
- To explore opportunities for digital accommodations.
Main Methods:
- Two rounds of semi-structured interviews with 11 participants.
- Exploration of declarative knowledge, procedural skills, and work strategies.
- Analysis of task flows and desired assistive technology support.
- Reflexive thematic analysis of transcribed interviews.
Main Results:
- Participants work in diverse roles and industries.
- Eagerness to use emerging AI tools for accommodation was observed.
- Lack of in-the-moment adjustability in AI tools was a key challenge.
- AI tool usage can reveal cognitive changes, leading to self-consciousness and abandonment.
Conclusions:
- People with cognitive changes are proactive in finding technological solutions for work.
- Existing digital tools require modification for better usability.
- The personal impact of adopting emerging AI tools needs further consideration.
Related Concept Videos
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

